Document Detail

53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a.
MedLine Citation:
PMID:  23027628     Owner:  NLM     Status:  Publisher    
p53-binding protein-1 (53BP1) plays a critical role in cell cycle checkpoint and DNA repair activities. Recently, 53BP1 was recognized as a potential tumor suppressor gene. In this report, we investigated its tumor suppressor function in breast cancer. In clinical samples, we observed a lower level of 53BP1 expression in the cancer lesions than in the matched non-tumor tissues. Furthermore, the 53BP1 level showed a gradual decrease during the progression from precancerous to cancer lesion. Ectopic expression of 53BP1 can significantly inhibit cell proliferation and curb the invasiveness in breast cancer cell lines, while knockdown of 53BP1 by RNA interference had the opposite effects.. Additionally, 53BP1 markedly inhibited xenograft formation and metastasis of breast cancer cells in nude mice. Both in vitro and vivo studies revealed that the 53BP1 expression level was inversely correlated to the function of nuclear factor kB (NF-κB), which contributes to the invasion and metastasis of breast cancer. Importantly, the inhibitory effect of 53BP1 on NF-κB activity was shown to be mediated by the upregulation of miR-146a. Together, our findings demonstrated that 53BP1 has a potent tumor suppressor activity in breast cancer and it may serve as a novel target for breast cancer prevention and treatment.
Xiaoyan Li; Bing Xu; Meena S Moran; Yuhan Zhao; Peng Su; Bruce G Haffty; Changshun Shao; Qifeng Yang
Related Documents :
23331018 - Proteomics using mammospheres as a model system to identify proteins deregulated in bre...
22658808 - A nomogram to predict individual prognosis in node-negative breast carcinoma.
24803138 - Quantitative analyses of ros and rns production in breast cancer cell lines incubated w...
23704778 - Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estr...
12359198 - Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients.
11257208 - Multisite phosphotyping of the erbb-2 oncoprotein in human breast cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-1
Journal Detail:
Title:  Carcinogenesis     Volume:  -     ISSN:  1460-2180     ISO Abbreviation:  Carcinogenesis     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8008055     Medline TA:  Carcinogenesis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Breast Surgery, Qilu Hospital, Shandong University, Wenhua Xi Road No.107, 250012 P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of genetic variants for colorectal cancer differs by subtypes of polyps in the colorectu...
Next Document:  Mid-Infrared HgTe/As(2) S(3) Field Effect Transistors and Photodetectors.